Saturday, May 30, 2026
The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Steven Kussick, MD, PhD

Steven Kussick, MD, PhD

PhenoPath

In addition to Medical Director, Steven J. Kussick, MD, PhD, is Director of Contract Research, and Director of Flow Cytometry at PhenoPath Laboratories. He has extensive experience in the use of morphologic, immunophenotypic, and molecular methods in the diagnosis of hematolymphoid neoplasms. Dr. Kussick received his M.D. and Ph.D. from the Medical Scientist Training Program at the University of Washington, where he also completed his Anatomic Pathology Residency and Hematopathology Fellowship. He is board-certified in Anatomic Pathology and Hematopathology. Prior to joining PhenoPath, he was Attending Hematopathologist and Associate Director of Hematopathology in the Department of Laboratory Medicine at the University of Washington. At PhenoPath, Dr. Kussick established our 9-color flow cytometry laboratory in 2005, and transitioned the methodology to 10-color analysis in 2010. He has overseen the validation of numerous new IHC assays related to hematopathology. In addition to 14 years of attending experience in diagnostic hematopathology, Dr. Kussick has a broad research background, with over 35 peer-reviewed research publications in areas including flow cytometry, hematopathology, basic cancer biology and chronic disease epidemiology.